Dataset from A Multicenter, Randomized, Double-Blind, Placebo-Controlled Study Comparing the Efficacy and Safety of LY2439821 to Etanercept and Placebo in Patients With Moderate-to-Severe Plaque Psoriasis

NIAID Data Ecosystem2026-05-10 收录

银屑病临床试验

生物制剂疗效

数据链接：

https://doi.org/10.25934/00004502 数据链接链接失效反馈

官方服务：

资源简介：

This study will assess the safety and efficacy of ixekizumab (LY2439821) compared to etanercept and placebo in participants with moderate to severe chronic plaque psoriasis.

创建时间：

2026-03-13

Dataset from A Multicenter, Randomized, Double-Blind, Placebo-Controlled Study Comparing the Efficacy and Safety of LY2439821 to Etanercept and Placebo in Patients With Moderate-to-Severe Plaque Psoriasis

资源简介：

相关数据集